Hasil Filter

3

Total database: 17430
Struktur (SMILES)
1 (33.3%)
Target
2 (66.7%)
Genomik
0 (0%)
Referensi
3 (100.0%)

Tipe Molekul

Distribusi Wujud Zat

Status Regulasi

Hasil Pencarian (3)

Aflibercept Approved DB08885
biotech | CAS: 862111-32-8

Aflibercept is a recombinant protein composed of the binding domains of two human vascular endothelial growth factor (VEGF) receptors, VEGFR1 and VEGFR2, fused with the Fc region of human immunoglobulin gamma 1 (IgG1).[A261130] Structurally, Aflibercept is a …

Kategori:
Amino Acids, Peptides, and ProteinsAngiogenesis InhibitorsAngiogenesis Modulating Agents +16
Target Protein:
Vascular endothelial growth factor A, long formPlacenta growth factorVascular endothelial growth factor B
Waktu ParuhFor the intravitrea…
Vol. DistribusiThe volume of distr…
KlirensFollowing an hour o…
Genetik -
Faricimab Approved DB15303
biotech | CAS: 1607793-29-2

Retinal vascular diseases (RVDs) such as diabetic macular edema (DME), age-related macular degeneration (AMD), and retinal vein occlusion (RVO) are typically caused by retinal ischemia and subsequent neovascularization (NV).[A225985, A225990, A225995] Vascula…

Kategori:
Amino Acids, Peptides, and ProteinsAngiogenesis InhibitorsAngiogenesis Modulating Agents +15
Target Protein:
Vascular endothelial growth factor A, long formAngiopoietin-2
Waktu ParuhFaricimab has an es…
Vol. Distribusi-
Klirens-
Genetik -
Tabirafusp tedromer DB19340
small molecule | CAS: 2412170-98-8

Tabirafusp tedromer is under investigation in clinical trial NCT06556368 (A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneratio…

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -